These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 35582128)

  • 1. Novel approaches in search for biomarkers of cholangiocarcinoma.
    Mocan LP; Ilieș M; Melincovici CS; Spârchez M; Crăciun R; Nenu I; Horhat A; Tefas C; Spârchez Z; Iuga CA; Mocan T; Mihu CM
    World J Gastroenterol; 2022 Apr; 28(15):1508-1525. PubMed ID: 35582128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
    Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
    J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine.
    Gopal P; Robert ME; Zhang X
    Arch Pathol Lab Med; 2024 Mar; 148(3):359-370. PubMed ID: 37327187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.
    Shi Y; Deng X; Zhan Q; Shen B; Jin X; Zhu Z; Chen H; Li H; Peng C
    J Gastrointest Surg; 2013 Sep; 17(9):1584-91. PubMed ID: 23868055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
    Yao D; Kunam VK; Li X
    J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and bile biomarkers for cholangiocarcinoma.
    Alvaro D
    Curr Opin Gastroenterol; 2009 May; 25(3):279-84. PubMed ID: 19396965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocarcinoma.
    Khan AS; Dageforde LA
    Surg Clin North Am; 2019 Apr; 99(2):315-335. PubMed ID: 30846037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revision of potential prognostic markers of cholangiocarcinoma for clinical practice.
    Saengboonmee C; Obchoei S; Sawanyawisuth K; Wongkham S
    Expert Rev Anticancer Ther; 2023 May; 23(5):517-530. PubMed ID: 37052887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience.
    Hrudka J; Prouzová Z; Mydlíková K; Jedličková K; Holešta M; Whitley A; Havlůj L
    Pathol Oncol Res; 2021; 27():1609756. PubMed ID: 34257615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy.
    Sharif AW; Williams HR; Lampejo T; Khan SA; Bansi DS; Westaby D; Thillainayagam AV; Thomas HC; Cox IJ; Taylor-Robinson SD
    HPB (Oxford); 2010 Aug; 12(6):396-402. PubMed ID: 20662790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future directions in the treatment of cholangiocarcinoma.
    Zhu AX
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.
    Li L; Masica D; Ishida M; Tomuleasa C; Umegaki S; Kalloo AN; Georgiades C; Singh VK; Khashab M; Amateau S; Li Z; Okolo P; Lennon AM; Saxena P; Geschwind JF; Schlachter T; Hong K; Pawlik TM; Canto M; Law J; Sharaiha R; Weiss CR; Thuluvath P; Goggins M; Shin EJ; Peng H; Kumbhari V; Hutfless S; Zhou L; Mezey E; Meltzer SJ; Karchin R; Selaru FM
    Hepatology; 2014 Sep; 60(3):896-907. PubMed ID: 24497320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Yi X; Zhu J; Liu W; Peng L; Lu C; Sun P; Huang L; Nie X; Huang S; Guo T; Zhu Y
    Mol Cell Proteomics; 2023 Aug; 22(8):100604. PubMed ID: 37353004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic classification of cholangiocarcinoma: New concepts.
    Nakanuma Y; Kakuda Y
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
    Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
    J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.
    Macias RIR; Banales JM; Sangro B; Muntané J; Avila MA; Lozano E; Perugorria MJ; Padillo FJ; Bujanda L; Marin JJG
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1468-1477. PubMed ID: 28782657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
    Elvevi A; Laffusa A; Scaravaglio M; Rossi RE; Longarini R; Stagno AM; Cristoferi L; Ciaccio A; Cortinovis DL; Invernizzi P; Massironi S
    Ann Hepatol; 2022; 27(5):100737. PubMed ID: 35809836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis.
    Rahnemai-Azar AA; Weisbrod A; Dillhoff M; Schmidt C; Pawlik TM
    Surg Oncol; 2017 Jun; 26(2):125-137. PubMed ID: 28577718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.